Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta [5]

  1. Garcia, J.L.
  2. De Mora, J.F.
  3. Hernández, J.M.
  4. Queizan, J.A.
  5. Gutierrez, N.C.
  6. Hernandez, J.M.
  7. San Miguel, J.F.
Aldizkaria:
Blood

ISSN: 0006-4971

Argitalpen urtea: 2003

Alea: 102

Zenbakia: 7

Orrialdeak: 2699-2700

Mota: Gutuna

DOI: 10.1182/BLOOD-2003-05-1579 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus